Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Investing.com -- J.P. Morgan upgraded Bureau Veritas to “overweight” from “neutral” and raised its December 2027 price target to €34 from €28, citing faster organic growth and increased merger and acquisition activity.
The global testing, inspection, and certification (TIC) market is forecast to grow from USD 269.6 billion in 2026 to USD 414.5 billion by 2036, at a 4.4% CAGR. Growth is driven by stricter safety, quality, environmental, cybersecurity and ESG regulations, clean energy, transport electrification and industrial digitalization. Testing and outsourced TIC services will lead, while certification and healthcare grow fastest. Europe will hold the largest share, with Asia-Pacific expanding fastest. Key
Bureau Veritas (ENXTPA:BVI) has come back into focus after recent trading left the share price at €26.89, with mixed short term returns but a positive picture over the past 3 months. Recent trading tells a mixed story for Bureau Veritas, with a modest 1-day share price return of 0.49% but a softer 30-day share price return that declined 1.83%. Longer term momentum looks steadier, reflected in a 1-year total shareholder return of 7.56% and a 3-year total shareholder return of 26.17%. Scan...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.